ClinicalTrials.Veeva

Menu

Corneal Densitometry Changes With Adenoviral SEI

B

Benha University

Status

Completed

Conditions

Corneal Disease

Treatments

Drug: Tacrolimus ointment
Procedure: phototherapeutic keratectomy

Study type

Observational

Funder types

Other

Identifiers

NCT04267991
Hamaky5

Details and patient eligibility

About

Adenoviral Sub epithelial infiltrates (SEI) affect ocular function.They lead to reduced vision, photophobia, glare, halos, and foreign body sensation.

Full description

first group of patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.S econd group underwent transepithelial PTK for subepithelial infiltrates. Baseline and post-treatment full ophthalmic examination was done.

Enrollment

63 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adenoviral SEI

Exclusion criteria

  • Other corneal diseases

Trial design

63 participants in 3 patient groups

Tacrolimus
Description:
Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.
Treatment:
Drug: Tacrolimus ointment
Phototherapeutic Keratectomy
Description:
Patients underwent transepithelial PTK for subepithelial infiltrates.
Treatment:
Procedure: phototherapeutic keratectomy
Control
Description:
patients received only artificial tears eyedrop

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems